JAMP-Clopidogrel and AG-Clopidogrel recall in Canada: incorrect dose
In plain language
This recall involves JAMP-Clopidogrel 75 mg and AG-Clopidogrel 75 mg tablets sold in Canada. They are being recalled because some tablets may contain an incorrect dose, which could lead to serious health risks. Continue taking the medication until you speak with your pharmacist and get a replacement product.
What to do
- Speak with your pharmacist as soon as possible.
- Continue taking your medication until you get a replacement product.
- Contact a healthcare professional immediately if you experience serious side effects.
- Contact JAMP Pharma Corporation or Angita Pharma Inc. with questions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
JAMP-Clopidogrel 75 mg tablets
Lot: EG22CGM002, EG22CGM003, EG22CGN001, EG23CGN001, EG23CGN002, EG23CGN003, EG23CGM001, EG23CGL001, EG23CGN004
Date codes: 2025-09-30, 2026-05-31, 2026-07-31
AG-Clopidogrel 75 mg tablets
Lot: EG23AGH001, EG23AGM001
Date codes: 2026-07-31
Why this matters
Incorrect dose risk
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the date code
Date codes are usually printed near the best-before date or on the packaging seam.
Affected date codes: 2025-09-30, 2026-05-31, 2026-07-31
- 3
Check the lot number
Lot numbers identify specific production batches.
Affected lots: EG22CGM002, EG22CGM003, EG22CGN001, EG23CGN001, EG23CGN002, EG23CGN003, EG23CGM001, EG23CGL001, EG23CGN004, EG23AGH001, EG23AGM001
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Incorrect dose risk
What should consumers do?
Speak with your pharmacist as soon as possible. Continue taking your medication until you get a replacement product. Contact a healthcare professional immediately if you experience serious side effects. Contact JAMP Pharma Corporation or Angita Pharma Inc. with questions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Incorrect dose risk
When was this product recalled?
This product was recalled on September 5, 2024.
Is the JAMP-Clopidogrel, AG-Clopidogrel brand affected by this recall?
Yes, JAMP-Clopidogrel, AG-Clopidogrel products are affected by this recall. This recall involves JAMP-Clopidogrel 75 mg and AG-Clopidogrel 75 mg tablets sold in Canada. They are being recalled because some tablets may contain an incorrect dose, which could lead to serious health risks. Continue taking the medication until you speak with your pharmacist and get a replacement product.